Please enable JS

Axonal Biostatem

For more than 30 years, AXONAL BIOSTATEM supported their clients in the design, implementation and analysis of their clinical research projects and non-interventional studies. While offering a European and international coverage, their medical and scientific expertise as well as their ability to adapt to the specificities of each project, helped them become a solid and sustainable company.

 

Their main goals consist of  supporting medical research stakeholders to obtain reliable and honest data, facilitating early patient access to innovative therapies and reducing the environmental impact of their activities.

 

Learn more: www.axonalbiostatem.com

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

3 million +

patients
in database

50 000 +

users
worlwide

telemedicine technologies earth

LATEST NEWSOUR NEWS >

telemedecine technologies news

Evolving toward empowerment: how we are deepening relationships with patients

November 28, 2024

Applied Clinical Trials Online Multilayered strategies such as working with patient advocacy organizations and leveraging technology can help industry better partner with patients. atients are more than participants; they are partners in clinical research. As clinical research evolves, so does the way we regard this relationship. Today, global regulatory pressures combined with ethical imperatives are […]

READ MORE
telemedecine technologies news

Reducing clinical and staff burnout with AI automation

November 28, 2024

Med City News As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers. Burnout among clinicians and staff remains a significant issue in healthcare, with widespread implications for patient care, staff retention, and the financial health of healthcare organizations. According to recent survey data from the American Medical Association, nearly half of […]

READ MORE
telemedecine technologies news

FDA finalizes decentralized clinical trial guidance

November 28, 2024

Applied Clinical Trials Online The FDA’s guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas. Decentralized clinical trials (DCTs) are clinical trials in which some or all trial-related activities occur at locations other […]

READ MORE